These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21454067)

  • 1. Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.
    Le Meur Y; Borrows R; Pescovitz MD; Budde K; Grinyo J; Bloom R; Gaston R; Walker RG; Kuypers D; van Gelder T; Kiberd B
    Transplant Rev (Orlando); 2011 Apr; 25(2):58-64. PubMed ID: 21454067
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic drug monitoring of mycophenolates: why make simple things complicated?
    Kuypers DR; van Gelder T
    Transplant Rev (Orlando); 2011 Apr; 25(2):45-6. PubMed ID: 21477747
    [No Abstract]   [Full Text] [Related]  

  • 3. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic monitoring of mycophenolic acid. A consensus panel report.
    Shaw LM; Nicholls A; Hale M; Armstrong VW; Oellerich M; Yatscoff R; Morris RE; Holt DW; Venkataramanan R; Haley J; Halloran P; Ettenger R; Keown P; Morris RG
    Clin Biochem; 1998 Jul; 31(5):317-22. PubMed ID: 9721428
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?
    Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H
    Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
    Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL
    Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic drug monitoring for mycophenolic acid is value for (little) money.
    van Gelder T
    Clin Pharmacol Ther; 2011 Aug; 90(2):203-4. PubMed ID: 21772294
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report.
    Cantarovich M; Brown NW; Ensom MH; Jain A; Kuypers DR; Van Gelder T; Tredger JM
    Transplant Rev (Orlando); 2011 Apr; 25(2):65-77. PubMed ID: 21454066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic monitoring of mycophenolate mofetil.
    Jeong H; Kaplan B
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403
    [No Abstract]   [Full Text] [Related]  

  • 11. Is mycophenolate mofetil better than azathioprine in organ transplantation?
    Ruggenenti P; Remuzzi G
    Transplantation; 2006 Nov; 82(9):1242-3. PubMed ID: 17102781
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Langman LJ; LeGatt DF
    Transplant Proc; 1996 Dec; 28(6):3013-5. PubMed ID: 8962169
    [No Abstract]   [Full Text] [Related]  

  • 13. MYSS: should we alter clinical practice?
    Maes B; Vanrenterghem Y
    Lancet; 2004 Dec 4-10; 364(9450):2016-7; author reply 2017-8. PubMed ID: 15582052
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
    [No Abstract]   [Full Text] [Related]  

  • 15. Scientific principles for mycophenolic acid therapeutic drug monitoring.
    Shaw LM; Korecka M; Aradhye S; Grossman R; Barker C; Naji A; Brayman KL
    Transplant Proc; 1998 Aug; 30(5):2234-6. PubMed ID: 9723454
    [No Abstract]   [Full Text] [Related]  

  • 16. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.
    Shaw LM; Holt DW; Oellerich M; Meiser B; van Gelder T
    Ther Drug Monit; 2001 Aug; 23(4):305-15. PubMed ID: 11477311
    [No Abstract]   [Full Text] [Related]  

  • 17. Show me the money--immunosuppression in kidney transplantation.
    Burke GW; Ciancio G
    Lancet; 2004 Aug 7-13; 364(9433):481-3. PubMed ID: 15302174
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new immunosuppressor: CellCept].
    Mouly-Bandini A
    Presse Med; 2001 Jan; 30(2):66-7. PubMed ID: 11244816
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy.
    Manfro RC; Vedolin L; Cantarelli M; Oppitz P; Antunes AC; Rieder CR
    Transpl Infect Dis; 2009 Apr; 11(2):189-90. PubMed ID: 19210690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.